REC — Recordati Industria Chimica E Farmaceutica SpA Share Price
Last trade - 00:00- €10.18bn
- €11.77bn
- €2.08bn
- 88
- 16
- 85
- 71
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.66 | ||
| PEG Ratio (f) | 0.84 | ||
| EPS Growth (f) | 30.37% | ||
| Dividend Yield (f) | 2.87% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.04 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 99.76 | ||
| Price to Sales | 4.89 | ||
| EV to EBITDA | 16.76 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.46% | ||
| Return on Equity | 24.08% | ||
| Operating Margin | 26.87% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1,481.85 | 1,448.87 | 1,580.07 | 1,853.31 | 2,082.33 | 2,290.13 | 2,423.41 | 9.02% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +17.15 | -2.94 | +10.7 | -16.73 | +8.95 | +42.35 | +9.27 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.
Directors
- Alfredo Altavilla NEC (57)
- Andrea Recordati CEO (50)
- Guido Guidi VCH
- Luigi Corte CFO
- Corrado Castellucci EVP
- Alberto Martinez EVP
- Roberto Teruzzi EVP
- Giuseppe Gualazzini SVP (62)
- Raffaele Sabia SVP
- Gabriele Finzi VPR
- Daria Ghidoni VPR
- Miguel Isla Rodriguez VPR
- Scott Pescatore VPR
- Cedric Ripert VPR
- Witold Urban VPR
- Ismail Recep Yormaz VPR
- Fritz Squindo GMG (65)
- Enrico Baroncia GMG
- Giorgio De Palma EDR (46)
- Giampiero Mazza EDR (51)
- Cathrin Petty EDR (48)
- Federica De Medici DIR
- Giovanni Minora OTH
- Michaela Castelli LED (50)
- Francesco Balestrieri DRC
- Piergiorgio Peluso IND
- Silvia Elisabetta Candini NID (50)
- Joanna Le Couilliard NID (58)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 1st, 1970
- Public Since
- January 1st, 1984
- No. of Employees
- 4,455
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Borsa Italiana
- Shares in Issue
- 206,006,112
- Address
- Via Matteo Civitali, 1, MILANO, 20148
- Web
- https://recordati.com/
- Phone
- +39 02487871
- Auditors
- Ernst & Young SpA
Latest News for REC
Upcoming Events for REC
Q1 2024 Recordati Industria Chimica e Farmaceutica SpA Earnings Release
Dividend For RICFY.PK - 0.1711 USD
Dividend For RECI.MI - 0.6300 EUR
Q2 2024 Recordati Industria Chimica e Farmaceutica SpA Earnings Release
Similar to REC
Friulchem SpA
Borsa Italiana
Pharmanutra SpA
Borsa Italiana
Shedir Pharma Srl Unipersonale
Borsa Italiana
FAQ
As of Today at 19:18 UTC, shares in Recordati Industria Chimica E Farmaceutica SpA are trading at €49.42. This share price information is delayed by 15 minutes.
Shares in Recordati Industria Chimica E Farmaceutica SpA last closed at €49.42 and the price had moved by +22.6% over the past 365 days. In terms of relative price strength the Recordati Industria Chimica E Farmaceutica SpA share price has outperformed the FTSE Global All Cap Index by +13.09% over the past year.
The overall consensus recommendation for Recordati Industria Chimica E Farmaceutica SpA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The Recordati Industria Chimica E Farmaceutica SpA dividend yield is 2.43% based on the trailing twelve month period.
Last year, Recordati Industria Chimica E Farmaceutica SpA paid a total dividend of €1.20, and it currently has a trailing dividend yield of 2.43%.Looking ahead, shares in Recordati Industria Chimica E Farmaceutica SpA are due to go ex-dividend on 2024-05-20 and the next dividend pay date is 2024-05-22.
Recordati Industria Chimica E Farmaceutica SpA are due to go ex-dividend on 2024-05-20 and the next dividend pay date is 2024-05-22. The historic dividend yield on Recordati Industria Chimica E Farmaceutica SpA shares is currently 2.43%.
To buy shares in Recordati Industria Chimica E Farmaceutica SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €49.42, shares in Recordati Industria Chimica E Farmaceutica SpA had a market capitalisation of €10.18bn.
Here are the trading details for Recordati Industria Chimica E Farmaceutica SpA:
- Country of listing: Italy
- Exchange: MIL
- Ticker Symbol: REC
Based on an overall assessment of its quality, value and momentum Recordati Industria Chimica E Farmaceutica SpA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Recordati Industria Chimica E Farmaceutica SpA is €50.90. That is 2.99% above the last closing price of €49.42.
Analysts covering Recordati Industria Chimica E Farmaceutica SpA currently have a consensus Earnings Per Share (EPS) forecast of €2.45 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Recordati Industria Chimica E Farmaceutica SpA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -2.46%.
As of the last closing price of €49.42, shares in Recordati Industria Chimica E Farmaceutica SpA were trading +4.87% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Recordati Industria Chimica E Farmaceutica SpA PE ratio based on its reported earnings over the past 12 months is 19.66. The shares last closed at €49.42.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Recordati Industria Chimica E Farmaceutica SpA's management team is headed by:
- Alfredo Altavilla - NEC
- Andrea Recordati - CEO
- Guido Guidi - VCH
- Luigi Corte - CFO
- Corrado Castellucci - EVP
- Alberto Martinez - EVP
- Roberto Teruzzi - EVP
- Giuseppe Gualazzini - SVP
- Raffaele Sabia - SVP
- Gabriele Finzi - VPR
- Daria Ghidoni - VPR
- Miguel Isla Rodriguez - VPR
- Scott Pescatore - VPR
- Cedric Ripert - VPR
- Witold Urban - VPR
- Ismail Recep Yormaz - VPR
- Fritz Squindo - GMG
- Enrico Baroncia - GMG
- Giorgio De Palma - EDR
- Giampiero Mazza - EDR
- Cathrin Petty - EDR
- Federica De Medici - DIR
- Giovanni Minora - OTH
- Michaela Castelli - LED
- Francesco Balestrieri - DRC
- Piergiorgio Peluso - IND
- Silvia Elisabetta Candini - NID
- Joanna Le Couilliard - NID